Moreover, it has been suggested that a subset of CRC patients harbors mutations in HR genes, including ATM serine/threonine kinase (ATM), BRCA1/2, MRE11A, FA complementation group C (FANCC), NBS1, and PALB2 [20]. This evidence concerns the gene NBN and colorectal carcinoma.